JAYA ASIRVATHAM to Biomarkers, Tumor
This is a "connection" page, showing publications JAYA ASIRVATHAM has written about Biomarkers, Tumor.
Connection Strength
1.085
-
Acinic Cell Carcinoma of the Breast: Report of a Case With Immunohistochemical and Next-Generation Sequencing Studies. Int J Surg Pathol. 2021 Dec; 29(8):882-886.
Score: 0.434
-
Role of PAX-8, CD5, and CD117 in distinguishing thymic carcinoma from poorly differentiated lung carcinoma. Appl Immunohistochem Mol Morphol. 2014 May-Jun; 22(5):372-6.
Score: 0.269
-
Immunohistochemical Expression of CDX2 and SATB2 in Primary Breast Carcinomas. Appl Immunohistochem Mol Morphol. 2020 07; 28(6):e53.
Score: 0.103
-
Myxoid Myofibroblastoma of the Breast With Atypical Cells. Int J Surg Pathol. 2019 Jun; 27(4):446-449.
Score: 0.093
-
NUT (Nuclear Protein in Testis) Carcinoma: A Report of Two Cases With Different Histopathologic Features. Int J Surg Pathol. 2019 Apr; 27(2):225-229.
Score: 0.091
-
Ossifying fibromyxoid tumor of the breast mimicking fibroadenoma: a case report and differential diagnoses. Arch Pathol Lab Med. 2014 Aug; 138(8):1098-100.
Score: 0.068
-
HER-2/neu-positive breast cancer neoadjuvant chemotherapy response after implementation of 2018 ASCO/CAP focused update. Breast J. 2021 08; 27(8):631-637.
Score: 0.027